FDA Extends Comment Period for Emerging Medical Device Signals Draft Guidance
January 28, 2016
On December 31, 2015, FDA released a draft guidance entitled “Public Notification of Emerging Postmarket Medical Device Signals (‘Emerging Signals’),” which stated its plans to take a more aggressive approach to reporting medical device safety warnings to the public.
When the draft guidance was initially published the FDA stated that anyone interested in providing feedback on the document would have until February 29, 2016 to do so. However, “due to the unanticipated high-level of interest from external stakeholders and the medical device community,” the Agency is extending that deadline. On Wednesday, January 27, FDA announced that interested persons will now have until March 29, 2016 to submit any comments, questions, or concerns on the draft guidance.
Are you in the process of developing a medical device? Do you have a device that needs FDA approval? We can help. Using our proprietary approach, we can help get your product through FDA cheaper, better, and faster. To learn more about our services and how we can help you, contact us today.
FDA Extends Comment Period For Its “Request for Quality Metrics” Draft Guidance
Last month, FDA published a draft guidance titled “Request for Quality Metrics,” which outlined the ways in which it intends to collect and use quality metrics. The guidance states that the data will...